Abstract:Alzheimer’s disease (AD) and type 2 diabetes (T2D) are among the most prevalent chronic diseases affecting the aging population. Extensive research evidence indicates that T2D is a well-established risk factor for AD; however, the molecular mechanisms underlying this association have not been fully elucidated. Furthermore, how T2D may contribute to the progression of AD is a subject of extensive investigation. In this study, we compared the blood transcriptome of patients with mild cognitive impairment (MCI), … Show more
“…The role of both insulin and sphingolipids is well documented in AD and other neurodegenerative diseases [49,50]. Impaired insulin signaling and diabetes have been extensively implicated in the pathogenesis of AD [13,37]. Sphingolipids are key components of cell membranes and play a pivotal role in mediating neuroinflammation, a central pathway involved in the pathogenesis of AD.…”
Section: Discussionmentioning
confidence: 99%
“…For every two datasets, the genetic overlap among the different gene expression datasets was analyzed as previously described [13,59]. Briefly, BSCE used a 'Running Fisher' algorithm to overlap the p values between different gene expression datasets [59].…”
Section: Transcriptomic Analysis Of Gene Expression Datasets From Admentioning
confidence: 99%
“…A p-value of 0.05 or less was considered significant. Microarray meta-analyses of the AD datasets were performed in BSCE as described previously [13,60]. The Venn diagrams and the correlation graphs were obtained from BSCE.…”
Section: Transcriptomic Analysis Of Gene Expression Datasets From Admentioning
confidence: 99%
“…Indeed, there is no fully validated biomarker with the required sensitivity and specificity for accurately diagnosing patients within the dementia spectrum. Network-based approaches have been useful for revealing some of the mechanistic pathways involved in the development of different dementias including, AD [10][11][12][13][14], VaD [15], and FTD [16][17][18]. Very few studies, however, have employed network-based approaches for identifying unique features that could help distinguishing dementias.…”
Background: Dementia is a growing public health concern with an estimated prevalence of 50 million people worldwide. Alzheimer’s disease (AD) and vascular and frontotemporal dementias (VaD, FTD), share many clinical, genetical, and pathological features making the diagnosis difficult. Methods: In this study, we compared the transcriptome from the frontal cortex of patients with AD, VaD, and FTD to identify dysregulated pathways. Results: Upregulated genes in AD were enriched in adherens and tight junctions, mitogen-activated protein kinase, and phosphatidylinositol 3-kinase and protein kinase B/Akt signaling pathways, whereas downregulated genes associated with calcium signaling. Upregulated genes in VaD were centered on infectious diseases and nuclear factor kappa beta signaling, whereas downregulated genes are involved in biosynthesis of amino acids and the pentose phosphate pathway. Upregulated genes in FTD were associated with ECM receptor interactions and the lysosome, whereas downregulated genes were involved in glutamatergic synapse and MAPK signaling. The transcription factor KFL4 was shared among the 3 types of dementia. Conclusions: Collectively, we identified similarities and differences in dysregulated pathways and transcription factors among the dementias. The shared pathways and transcription factors may indicate a potential common etiology, whereas the differences may be useful for distinguishing dementias.
“…The role of both insulin and sphingolipids is well documented in AD and other neurodegenerative diseases [49,50]. Impaired insulin signaling and diabetes have been extensively implicated in the pathogenesis of AD [13,37]. Sphingolipids are key components of cell membranes and play a pivotal role in mediating neuroinflammation, a central pathway involved in the pathogenesis of AD.…”
Section: Discussionmentioning
confidence: 99%
“…For every two datasets, the genetic overlap among the different gene expression datasets was analyzed as previously described [13,59]. Briefly, BSCE used a 'Running Fisher' algorithm to overlap the p values between different gene expression datasets [59].…”
Section: Transcriptomic Analysis Of Gene Expression Datasets From Admentioning
confidence: 99%
“…A p-value of 0.05 or less was considered significant. Microarray meta-analyses of the AD datasets were performed in BSCE as described previously [13,60]. The Venn diagrams and the correlation graphs were obtained from BSCE.…”
Section: Transcriptomic Analysis Of Gene Expression Datasets From Admentioning
confidence: 99%
“…Indeed, there is no fully validated biomarker with the required sensitivity and specificity for accurately diagnosing patients within the dementia spectrum. Network-based approaches have been useful for revealing some of the mechanistic pathways involved in the development of different dementias including, AD [10][11][12][13][14], VaD [15], and FTD [16][17][18]. Very few studies, however, have employed network-based approaches for identifying unique features that could help distinguishing dementias.…”
Background: Dementia is a growing public health concern with an estimated prevalence of 50 million people worldwide. Alzheimer’s disease (AD) and vascular and frontotemporal dementias (VaD, FTD), share many clinical, genetical, and pathological features making the diagnosis difficult. Methods: In this study, we compared the transcriptome from the frontal cortex of patients with AD, VaD, and FTD to identify dysregulated pathways. Results: Upregulated genes in AD were enriched in adherens and tight junctions, mitogen-activated protein kinase, and phosphatidylinositol 3-kinase and protein kinase B/Akt signaling pathways, whereas downregulated genes associated with calcium signaling. Upregulated genes in VaD were centered on infectious diseases and nuclear factor kappa beta signaling, whereas downregulated genes are involved in biosynthesis of amino acids and the pentose phosphate pathway. Upregulated genes in FTD were associated with ECM receptor interactions and the lysosome, whereas downregulated genes were involved in glutamatergic synapse and MAPK signaling. The transcription factor KFL4 was shared among the 3 types of dementia. Conclusions: Collectively, we identified similarities and differences in dysregulated pathways and transcription factors among the dementias. The shared pathways and transcription factors may indicate a potential common etiology, whereas the differences may be useful for distinguishing dementias.
“…Although numerous pieces of evidence suggest a shared pathophysiology between AD and DM in the brain and pancreatic tissues, few studies have compared their whole blood transcriptome signatures [ 18 ]. Santiago et al [ 18 ] performed a microarray meta-analysis of blood RNA expression in the blood of AD and DM patients and mainly conducted differential expression (DE) analysis to identify common mechanisms between the two diseases. Another brain microarray meta-analysis study conducted a differential connectivity (DC) analysis, yielding TYROBP as an upstream regulator of AD [ 19 ].…”
Alzheimer’s disease (AD) and diabetes mellitus (DM) are known to have a shared molecular mechanism. We aimed to identify shared blood transcriptomic signatures between AD and DM. Blood expression datasets for each disease were combined and a co-expression network was used to construct modules consisting of genes with similar expression patterns. For each module, a gene regulatory network based on gene expression and protein-protein interactions was established to identify hub genes. We selected one module, where COPS4, PSMA6, GTF2B, GTF2F2, and SSB were identified as dysregulated transcription factors that were common between AD and DM. These five genes were also differentially co-expressed in disease-related tissues, such as the brain in AD and the pancreas in DM. Our study identified gene modules that were dysregulated in both AD and DM blood samples, which may contribute to reveal common pathophysiology between two diseases.
Aims: African Americans (AA) in the United States have a high risk of type 2 diabetes mellitus (T2DM) and suffer from disparities in the prevalence, mortality, and comorbidities of the disease compared to other Americans. The present study aimed to shed light on the molecular mechanisms of disease pathogenesis of T2DM among AA in the Washington, DC region.
Methods:We performed TaqMan Low Density Arrays (TLDA) on 24 genes of interest that belong to three categories: metabolic disease and disorders, cancer-related genes, and neurobehavioural disorders genes. The 18 genes, viz.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.